Dr. Bennet and SONAR Submits New Citizen Petition Regarding FQAD
Dr. Bennett and Southern Network For Adverse Reactions (SONAR) have submitted another Citizen Petition to the FDA requesting new Fluoroquinolone Black Box Warning.
Tagged: Dr. Bennett
FDA Levaquin Label Update
The separate “Psychiatric Adverse Events” section was FINALLY added to the Levaquin label and it includes the additional psychiatric adverse events.
Cipro: A Mitochondrial Killing Machine
In this article I refute the smoking gun scenario, discuss why some people seemingly do not have adverse events, reveal why Cipro damages the brain, why they are still on the market, and, again, reiterate just how horribly damaging the FQ’s are to mitochondria.
Dr. Bennett Publishes Suicide Risk Academic Paper With Help From The Fluoroquinolone Community
Recently, in July 2018, Dr. Bennett published a paper about Fluoroquinolone Associated Suicide to the European Journal of Internal Medicine with the assistance of the floxed community.
Another Milestone Crossed: Fluoroquinolones, The FDA, and Psychiatric Adverse Events
In an astonishing statement from the FDA, they acknowledged that since “Psychiatric Effects” will specifically be identified within the “Central Nervous System Effects” subheading, psychiatric adverse events are automatically assumed to be part of the existing Black Box warning.
Some of Dr. Bennett’s Requested Warnings Added by FDA
Adverse events added by the FDA are some of those requested by Dr. Bennett previously.
FDA Updating Warnings for Flouroquinolones
The FDA is strengthening the current warnings in the prescribing information that the fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects.
Hillary Clinton and Levaquin, A Teachable Moment
This is a good high profile opportunity for us to continue to warn the general public, family and friends about the dangers posed by the Fluoroquinolones.
FDA Fails to Go The Distance, Yet Again
I am ecstatic about the new label changes. But given the FDA’s past track record, I will not happy until every medical professional, who has the ability to prescribe a FQ, is familiar with the label changes and safety precautions.
FDA Shell Game? I Hope Not
I think it was no coincidence that the FDA denied the mitochondrial citizen petition during the same time frame that they approved label changes. Right now the FDA is not acknowledging even the risk of mitochondrial toxicity.
Dr. Bennett Publishes Paper on Fluoroquinolone Neuropsychiatric & Mitochondrial Toxicity
Dr. Charles Bennett has been able to successfully publish a paper titled “Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network.”
Becoming a Danger to One’s Self and/or Others by Taking a Fluoroquinolone
It is very disturbing that an antibiotic, which is often given out for routine infections, may result in violence, anger toward others, and horribly, may result in suicide-related adverse events.
FDA To Hold Upcoming Meeting on Fluoroquinolones
We believe that the attention given the Fluoroquinolones through the combined media stories, past rallies, citizen petitions, in addition to community members meeting directly with FDA officials, provided some of the impetus, in part, for the scrutiny of the Fluoroquinolones being prescribed for these common health conditions.
Fluoroquinolone Community Goes to the FDA: Pediatrics and Rhabdomyolysis
On August 24th, 2015, members from the FQ community met with staff from the FDA in a third meeting to address the various FDA failures to adequately warn the general public about the true dangers FQ’s pose to the general public, especially our children.
Fluoroquinolone Community Represented at UMDF Symposium, Washington, DC
Dr. Linda Martin, Dr. Alan Redd, David Melvin, and John Fratti submitted an abstract for the UMDF Symposium on behalf of the FQ community. We are pleased to announce that, after being peer-reviewed by the UMDF Abstract Review Committee, their abstract was selected as a poster for the Symposium.
Loading ...
